Correspondence
Dabigatran-induced esophagitis: A frequently overlooked adverse effect

https://doi.org/10.1016/j.ijcard.2016.03.178Get rights and content

Section snippets

Conflicts of interest

None.

Financial disclosures

None.

References (18)

  • O.J. Ziff et al.

    Individualized approaches to thromboprophylaxis in atrial fibrillation

    Am. Heart J.

    (2016)
  • K. Phan et al.

    Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation

    Int. J. Cardiol.

    (2015)
  • R. Providencia et al.

    Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis

    Heart

    (2014)
  • P. Bytzer et al.

    Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial

    Clin. Gastroenterol. Hepatol.

    (2013)
  • S.J. Connolly et al.

    Dabigatran versus warfarin in patients with atrial fibrillation

    N. Engl. J. Med.

    (2009)
  • K. Shibagaki et al.

    Dabigatran-induced asymptomatic esophageal mucosal injury

    Gastrointest. Endosc.

    (2016)
  • E. Liu et al.

    Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation

    J. Interv. Card. Electrophysiol.

    (2012)
  • M. Okada et al.

    Exfoliative esophagitis and esophageal ulcer induced by dabigatran

    Endoscopy

    (2012)
  • A. Ootani et al.

    Dabigatran-induced esophagitis

    Clin. Gastroenterol. Hepatol.

    (2014)
There are more references available in the full text version of this article.

Cited by (10)

View all citing articles on Scopus
View full text